Cerebral Protection in Transcatheter Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 363 participants.
Also called NCT02214277
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 363 participants
- Sponsor
- Claret Medical
- Registry
-
NCT02214277
-
- Other papers using this trial's data
- Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany
- Registry status
- Completed
Technical summary
Registry record NCT02214277. Randomized; double masking; primary purpose prevention. Start 2014-09 (registry gives no type); primary completion 2016-03 (actual). Results posted on 2018-05-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cerebral Protection in Transcatheter Aortic Valve Replacement
- Condition
- Severe Symptomatic Calcified Native Aortic Valve Stenosis
- Intervention (Device)
- Cerebral Protection System-The SENTINEL System with TAVR (transcatheter aortic valve replacement)
- Intervention (Device)
- TAVR
- Lead sponsor
- Claret Medical
Record details
- Record id
cardio:ct-nct02214277- Content hash
7d142c1b63a51d581a415fab5098456ab7703518ae1797786bdb301c732d111d